WuXi PharmaTech, a Shanghai-based open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, has received the 2015 Asian CRO Company of the Year award from Frost & Sullivan, a business research and consulting firm.

The award is part of the Frost & Sullivan Asia Pacific Best Practices Awards series, recognizing companies in Asia Pacific that demonstrate outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service and strategic product development.

WuXi is being recognized for its strong performance and continued investments in the Asia Pacific region. Frost & Sullivan cited WuXi’s local market knowledge, facilities, reputation for high-quality, rapid turnaround times, comprehensive customer support and strong commitment to the highest global regulatory standards.